What else can be prescribed for the same conditions as Cosentyx?
Cosentyx (secukinumab) is commonly prescribed for several inflammatory diseases, including plaque psoriasis and certain psoriatic/immune-mediated arthritis conditions (and sometimes ankylosing spondylitis). Other prescription options depend on which condition you’re treating, how severe it is, and what treatments you’ve already tried.
Common alternatives to Cosentyx fall into several categories:
- Other biologics that block different inflammatory pathways (for example, IL-17/IL-23 or TNF inhibitors, depending on the specific condition and your treatment goals).
- Targeted small-molecule medicines (for some indications).
- Conventional systemic therapies (for certain cases, often used when biologics aren’t suitable).
If you’re on Cosentyx for plaque psoriasis, what are typical alternatives?
For plaque psoriasis, clinicians often consider switching within or across biologic classes. Examples of alternatives include:
- TNF inhibitors (often used for psoriasis and arthritis)
- IL-17 pathway agents (another IL-17 inhibitor rather than secukinumab)
- IL-23 pathway agents (which target a different step in immune signaling)
Which one is chosen usually comes down to prior response, side-effect history, comorbidities (like inflammatory bowel disease or arthritis), and insurance coverage.
If you’re on Cosentyx for psoriatic arthritis, what can replace it?
For psoriatic arthritis, alternatives commonly include:
- TNF inhibitors
- IL-17 pathway biologics
- IL-23 pathway biologics (depending on the exact clinical picture and prescribing guidance)
- Other targeted therapies or oral agents when appropriate
Doctors also consider whether you have significant skin symptoms, joint pattern, enthesitis, or dactylitis, since that can influence which class tends to work best.
If you’re on Cosentyx for ankylosing spondylitis (or axial spondyloarthritis), what else is used?
For ankylosing spondylitis/axial spondyloarthritis, alternatives often include:
- TNF inhibitors
- IL-17 pathway agents (since they target related inflammatory mechanisms)
- Other classes of prescription biologics or targeted therapies depending on region, eligibility, and response history
What happens if someone can’t take Cosentyx?
Switching options depend on the reason Cosentyx is not being continued, such as:
- Lack of effectiveness
- Side effects or lab abnormalities
- Recurrent infections
- Insurance/coverage limitations
In those cases, prescribers typically move to a different biologic class or to a different agent within the same pathway if it’s still considered appropriate.
How to find the best “what can I take instead” answer for your situation
If you tell me:
1) which condition you’re treating (psoriasis, psoriatic arthritis, ankylosing spondylitis, etc.),
2) whether you’re switching because it didn’t work or because of side effects, and
3) what other treatments you’ve already tried,
I can narrow the likely prescription alternatives to the most relevant options.
If you want, you can also share the dose (for example, every 2 weeks vs monthly) and your age, and I’ll tailor the alternatives more closely.
Source